Home Health Care News November 2, 2022
Some of the largest home health companies in the country have had the chance now to voice opinions on the final payment rule for 2023. Most all of them are dissatisfied it.
But what is unequivocally true is that the near-term relief it provides – versus what was expected – is major for companies across the country. It also, of course, gives those same providers and advocates even more time to stymie future cuts.
For Humana Inc. (NYSE: HUM), for instance, the payment cut delays in the final rule – released Monday – will have a relatively positive impact on the company’s 2023 financials.
“That would’ve been about a $30 million hit relative to our expectations,” Humana CFO Susan Diamond...
Today's Sponsors
Today's Sponsor